Path Traversal Vulnerability in ZKTeco BioAccess IVS
CVE-2023-38956

7.5HIGH

Key Information:

Vendor

Zkteco

Status
Bioaccess Ivs
Vendor
CVE Published:
3 August 2023

What is CVE-2023-38956?

A path traversal vulnerability in ZKTeco BioAccess IVS version 3.3.1 enables unauthenticated attackers to gain unauthorized access to sensitive files on the server. By supplying a specially crafted payload, attackers can manipulate file paths and read arbitrary files, potentially exposing critical information and compromising system security.

References

http://zkteco.com
https://claroty.com/team82/disclosure-dashboard/cve-2023-...

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

.